Federal Register / Vol. 65, No. 116 / Thursday, June 15, 2000 / Notices 37565

Dated: June 9, 2000.

Henry S. Cassell III,

Acting Director, Procurement and Grants

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 00–15116 Filed 6–14–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Guide to Community Preventive

Services Task Force; Notice of Meeting

Office of the Director, Centers for

Disease Control and Prevention (CDC),

announces the following meeting:

Name: Guide to Community Preventive

Services (GCPS) Task Force Meeting.

Times and Dates: 9 a.m.–5 p.m., June 21,

2000. 8:30 a.m.–3:15 p.m., June 22, 2000.

Place: The Radisson Hotel Atlanta Airport,

5010 Old National Highway, Atlanta, Georgia

30349, telephone (404) 761–4000.

Status: Open to the public, limited only by

the space available. The meeting room

accommodates approximately 40 people.

Purpose: The mission of the Task Force is

to develop and publish a Guide to

Community Preventive Services, which is

based on the best available scientific

evidence and current expertise regarding

essential public health services and what

works in the delivery of those services.

Matters to be Discussed: Agenda items

include: Final recommendation approvals on

the Tobacco Chapter, recommendation

approvals for the Oral Health, Physical

Activity, Sociocultural Environment, and

Sexual Behavior Chapters, an update on

dissemination/evaluation plans, updates for

the following chapters: Nutrition, Alcohol

Use and Misuse, Prevention of Mental

Disorders, Cancer, Motor Vehicle Occupant

Injury (seat belts and Alcohol Impaired

Driving), Violent and Abusive Behavior, and

Diabetes, summaries of economic evaluations

from the Tobacco Chapter, a general update

on economic evaluations from other chapters,

and briefings on cross-cutting activities

including methods development and

development of a cross-cutting chapter.

Agenda items are subject to change as

priorities dictate.

Contact Person for Additional Information:

Bradford Myers, Deputy Director,

Community Guide Section, Division of

Prevention Research and Analytic Methods,

Epidemiology Program Office, CDC, 4770

Buford Highway, M/S K–73, Atlanta, Georgia

30341, telephone 770/488–8189.

Persons interested in reserving a space for

this meeting should call 770/488–8189 by

close of business on June 19, 2000.

The Director, Management Analysis and

Services office has been delegated the

authority to sign Federal Register notices

pertaining to announcements of meetings and

other committee management activities, for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: June 12, 2000.

John Burckhardt,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention.

[FR Doc. 00–15245 Filed 6–14–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Blood Donor Recruitment Practices;

Public Workshop

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice of meeting.

The Food and Drug Administration

(FDA) is announcing the following

public workshop: Blood Donor

Recruitment Practices. The purpose of

the workshop is to gather information

on recruiting blood donors and to

develop recommendations on the best

practices in donor recruitment in the

United States.

Date and Time: The public workshop

will be held on July 6, 2000, 8:30 a.m.

to 5 p.m; and on July 7, 2000, 8:30 a.m.

to 2 p.m.

Locations: The July 6, 2000, workshop

will be held at the National Institutes of

Health, Lister Hill Center, 8600

Rockville Pike, Bldg. 38A, Bethesda,

MD. The July 7, 2000, workshop will be

held at the same location, and then will

move to the Natcher Conference Center,

45 Center Dr., Bldg. 45, for breakout

sessions.

Contact: Joseph Wilczek, Center for

Biologics Evaluation and Research

(HFM–302), Food and Drug

Administration, 1401 Rockville Pike,

Rockville, MD 20852; 301–827–6129;

FAX: 301–827–2843; e-mail:

wilczek@cber.fda.gov.

Registration: Early registration is

recommended on or before June 23,

2000. Mail or fax registration

information (including name, title, firm

name, address, telephone, and fax

number) to Joseph Wilczek (address

above). Registration at the site will be on

a space-available basis on the day of the

workshop, beginning at 7:30 a.m. There

is no registration fee for the workshop.

If you need special accommodations

due to a disability, please contact Joseph

Wilczek at least 7 days in advance.

Agenda: During the first day of the

workshop, speakers from the blood bank

industry will describe successful

recruitment practices. The topics of the

presentations will include methods

used in successful programs, donor

perception, donor retention, telephone

recruiting and scheduling, cooperative

recruiting in a competitive environment,

advertising, education, incentives, and

coordinating blood collection with

anticipated needs. During the second

day, attendees will break into small

groups to further discuss key donor

recruitment issues. The group

discussions will be developed into

recommendations of the best practices

most likely to increase blood collection

to levels sufficient to meet future

transfusion needs. At the close of the

second day, the attendees will

reconvene to share the group

recommendations. The information

gathered at the workshop may provide

the basis for an FDA document on best

practices in donor recruitment.

Transcripts: Transcripts of the

meeting may be requested in writing

from the Freedom of Information Office

(HFI–35), Food and Drug

Administration, 5600 Fishers Lane, rm.

12A–16, Rockville, MD 20857,

approximately 15 working days after the

meeting at a cost of 10 cents per page.

In addition, the transcript will be placed

on the FDA Internet site at

www.fda.gov/cber/minutes/workshopmin.htm.

Dated: June 7, 2000.

William K. Hubbard,

Senior Associate Commissioner for Policy,

Planning, and Legislation.

[FR Doc. 00–14904 Filed 6–14–00; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Circulatory System Devices Panel of

the Medical Devices Advisory

Committee; Notice of Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

This notice announces a forthcoming

meeting of a public advisory committee

of the Food and Drug Administration

(FDA). At least one portion of the

meeting will be closed to the public.

Name of Committee: Circulatory

System Devices Panel of the Medical

Devices Advisory Committee.

General Function of the Committee:

To provide advice and

recommendations to the agency on

FDA’s regulatory issues.